The invention relates to the technical field of
traditional Chinese medicine research, in particular to a discovery method of a cough relieving and
phlegm eliminating quality marker of cough relieving granules and the quality marker. According to the application, the cough-relieving and
phlegm-eliminating
drug effects of the cough-relieving granules are evaluated by virtue of concentrated
ammonia water cough inducing and
phenol red
excretion tests,
plasma pharmaceutical
chemistry research of the cough-relieving granules is developed by virtue of a UHPLC-Q-Exactive Plus
Orbitrap HRMS technology, and 26 prototype blood-entering components of the cough-relieving granules are analyzed and identified; through network pharmacological analysis of components entering blood, 11 potential
active components for relieving cough and eliminating
phlegm of the cough-relieving granules are screened, relate to 40 common targets such as IL6, TLR4, STAT3 and the like, and mainly participate in
signal channels such as PI3K-Akt, HIF-1, EGFR (
epidermal growth factor receptor) and the like; the seven prototype blood-entering components are quantitatively analyzed by utilizing
pharmacokinetics. The three compounds of
azelaic acid,
caffeic acid and
vanillin are used as the cough relieving and phlegm eliminating quality markers of the cough relieving granules through effectiveness, transitivity and
testability. The
research result is of great significance in deeply defining the pharmacodynamic material basis of the cough-relieving granules, optimizing the
quality standard and promoting the clinical application of the cough-relieving granules.